|
(P1448) |
A DW-MRI and MSCT-Study to assess predictors of cerebral embolism during transcatheter aortic valve implantation |
| |
|
K. Bijuklic, E. Yzeiraj, T. Haselbach, J. Witt, K. Krause, L. Hansen, F.-C. Rieß, J. Schofer (Hamburg) |
|
(P1449) |
Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes |
| |
|
J. Mosch, C. A. Gleißner, S. Body, E. Aikawa (Heidelberg; Boston, US) |
|
(P1450) |
Influence of Calcium, implantation depth and oversizing on occurrence of conduction disturbances and need for pacemaker implantation after implantation of the balloon-expandable Edwards Sapien 3 valve |
| |
|
B. Gonska, A. von Keil, J. Seeger, C. Rodewald, S. Dragomir, D. Scharnbeck, W. Rottbauer, J. Wöhrle (Ulm) |
|
(P1451) |
Significance of projected aortic valve area at normal transvalvular flow in unmasking pseudo-severe, low-flow, low-gradient stenosis in patients referred for transcatheter aortic valve implantation |
| |
|
U. Fischer-Rasokat, W.-K. Kim, C. Liebetrau, J. Blumenstein, S. Möllmann, T. Walther, C. W. Hamm, H. Möllmann (Bad Nauheim) |
|
(P1452) |
Improvement of myocardial texture after TAVI as assessed by T2 mapping CMR |
| |
|
M. Gastl, V. Veulemans, S. M. Haberkorn, P. Behm, C. Jacoby, T. Zeus, M. Kelm, F. Bönner (Düsseldorf) |
|
(P1453) |
Impact of myocardial fibrosis measured by cardiac magnetic resonance imaging on reverse left ventricular remodelling after transcatheter aortic valve implantation |
| |
|
C. Merten, H. W. Beurich, D. Zachow, M. El-Mawardy, J. Jose, G. Richardt, M. Abdel-Wahab (Bad Segeberg) |